FDA Clearance Tracker · DEN220077
ProSense System
Last checked: Nov 19, 2026Latest source record: Oct 3, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Oct 3, 2025
De Novo granted
Time to decision
1,080 days
Received Oct 19, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN220077
- Device name
- ProSense System
- Applicant
- Icecure Medical
- Applicant location
- Caesarea, IL
- Received
- Oct 19, 2022
- Decided
- Oct 3, 2025
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.4355
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN220077
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Icecure Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260377 · Decided Feb 24, 2026 · 19 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
K240892 · Decided Jun 28, 2024 · 88 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
K183213 · Decided Dec 20, 2019 · 396 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.